Neoadjuvant chemotherapy with MVAC in bladder carcinoma: Is the feasibility really established? Of: Benadiba et al.: Neoadjuvant chemotherapy in muscular invasive bladder cancer: Complications and consequences on cystectomy, Pr Urol 2015; 25: 549-554

Coquard R.

首页> 外文期刊>Progres en urologie: journal de l’Association francaise d’urologie et de la Societefrancaise d’urologie >Neoadjuvant chemotherapy with MVAC in bladder carcinoma: Is the feasibility really established? Of: Benadiba et al.: Neoadjuvant chemotherapy in muscular invasive bladder cancer: Complications and consequences on cystectomy, Pr Urol 2015; 25: 549-554

【24h】

Neoadjuvant chemotherapy with MVAC in bladder carcinoma: Is the feasibility really established? Of: Benadiba et al.: Neoadjuvant chemotherapy in muscular invasive bladder cancer: Complications and consequences on cystectomy, Pr Urol 2015; 25: 549-554

机译：在膀胱癌中使用MVAC进行新辅助化疗：是否确实存在可行性？作者：Benadiba等人：肌浸润性膀胱癌的新辅助化疗：膀胱切除术的并发症和后果，Pr Urol 2015; 25：549-554

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Progres en urologie: journal de l’Association francaise d’urologie et de la Societefrancaise d’urologie》 |2015年第16期|共2页
作者
Coquard R.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 fre
中图分类泌尿科学（泌尿生殖系疾病）;
关键词
入库时间 2022-08-18 17:00:58

相似文献

外文文献
专利

1. Neoadjuvant chemotherapy with MVAC in bladder carcinoma: Is the feasibility really established? Of: Benadiba et al.: Neoadjuvant chemotherapy in muscular invasive bladder cancer: Complications and consequences on cystectomy, Pr Urol 2015; 25: 549-554 [J] . Coquard R. Progres en urologie: journal de l’Association francaise d’urologie et de la Societefrancaise d’urologie . 2015,第16期

机译：在膀胱癌中使用MVAC进行新辅助化疗：是否确实存在可行性？作者：Benadiba等人：肌浸润性膀胱癌的新辅助化疗：膀胱切除术的并发症和后果，Pr Urol 2015; 25：549-554
2. Reply to Eliezer M. Van Allen, Levi A. Garraway and Jonathan E. Rosenberg's Letter to the Editor re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.014 [J] . Groenendijk Floris H., van de Putte Elisabeth E. Fransen, van Rhijn Bas W. G., European urology . 2015,第2期

机译：回复Eliezer M. Van Allen，Levi A. Garraway和Jonathan E. Rosenberg致编辑的信，关于：Floris H. Groenendijk，Jeroen de Jong，Elisabeth E. Fransen van de Putte等。 ERBB2突变表征了对新辅助化学疗法有出色反应的肌肉浸润性膀胱癌亚组。 Eur Urol。在新闻。 http://dx.doi.org/10.1016/j.eururo.2015.01.014
3. Re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.014 [J] . Van Allen Eliezer M., Garraway Levi A., Rosenberg Jonathan E. European urology . 2015,第2期

机译：Re：Floris H. Groenendijk，Jeroen de Jong，Elisabeth E. Fransen Van de Putte，等。 ERBB2突变表征了肌肉侵入性膀胱癌的亚组，具有对Neoadjuvant化疗的优异反应。 EUR UROL。在新闻。 http://dx.doi.org/10.1016/j.eururo.2015.01.014
4. Predictive Biomarkers for Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer: A survey [C] . Hisham Abdeltawab, Fahmi Khalifa, Mohammed Ghazal, IEEE International Symposium on Signal Processing and Information Technology . 2018

机译：肌肉浸润性膀胱癌新辅助化疗反应的预测性生物标志物：一项调查
5. Using Preoperative Mri-guided Biopsies to Predict Pathologic Complete Response after Neoadjuvant Chemotherapy in Breast Cancer [D] . Kim, Jiyoon. 2019

机译：在乳腺癌新辅助化疗后使用术前Mri引导的活检来预测病理完全缓解
6. Comparative effectiveness of palliative chemotherapy versus neoadjuvant chemotherapy followed by radical cystectomy versus cystectomy followed by adjuvant chemotherapy versus cystectomy for regional node‐positive bladder cancer: A retrospective analysis: KCSG GU 17‐03 [O] . Woo Kyun Bae, Hyo Jin Lee, Se Hoon Park, 2019

机译：姑息化疗新辅助化疗根治性膀胱切除术与膀胱切除术辅助化疗与膀胱切除术对区域淋巴结阳性膀胱癌的比较疗效：回顾性分析：KCSG GU 17-03
7. MP26-17 COULD A HISTORY OF NON-MUSCLE INVASIVE BLADDER CANCER HAVE A PROGNOSTIC ROLE IN CT2-4AN0M0 BLADDER CANCER PATIENTS TREATED WITH RADICAL CYSTECTOMY AND NEOADJUVANT CHEMOTHERAPY? [O] . Emina Kayama*, Eiji Kikuchi, Kyohei Hakozaki, 2019

机译：MP26-17可能是非肌肉侵袭性膀胱癌的历史在CT2-4AN0M0膀胱癌患者中具有预后作用，治疗自由基膀胱切除术和Neoadjuvant化疗进行治疗吗？

Neoadjuvant chemotherapy with MVAC in bladder carcinoma: Is the feasibility really established? Of: Benadiba et al.: Neoadjuvant chemotherapy in muscular invasive bladder cancer: Complications and consequences on cystectomy, Pr Urol 2015; 25: 549-554

著录项

相似文献

相关主题

期刊订阅